NEPHROS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
NEPHROS, INC. (NEPH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $20.00 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2017-11-09
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2017-09-30 was $20.00K.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2017-06-30 was $98.00K.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2017-03-31 was $223.00K.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2015 was $234.00K, a 53.85% decline from fiscal 2014.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2014 was $507.00K, a 2.31% decline from fiscal 2013.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2013 was $519.00K, a 2.57% increase from fiscal 2012.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2012 was $506.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|---|
| 2017-09-30 | $20.00K 10-Q · filed 2017-11-09 | $118.00K derived: sum of 2 quarters · filed 2017-11-09 | $341.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $98.00K 10-Q · filed 2017-08-08 | $321.00K 10-Q · filed 2017-08-08 | ||
| 2017-03-31 | $223.00K 10-Q · filed 2017-05-09 | |||
| 2015-12-31 | $234.00K 10-K · filed 2016-03-30 | |||
| 2014-12-31 | $507.00K 10-K · filed 2016-03-30 | |||
| 2013-12-31 | $519.00K 10-K · filed 2015-04-15 | |||
| 2012-12-31 | $506.00K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |